Answer
Glyxambi should preferably be avoided during pregnancy as a precautionary measure, because there are no data on empagliflozin and linagliptin use in pregnant women and animal studies with empagliflozin showed adverse effects on postnatal development.
Sources for this answer
- Glyxambi 10 mg/5 mg film-coated tablets and Glyxambi 25 mg/5 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 14Document updated
Sources checked